Le Lézard
Classified in: Science and technology
Subjects: Personnel, Merger/Acquisition, Business Update

Zilliant Drives Another Year of Strong Bookings Growth in FY 2023


Zilliant, the leader in pricing lifecycle management, today announced it recently concluded a year of rapid growth, delivering two consecutive quarters of 60%+ growth in year-over-year bookings.

The company is positioned for continued record growth in 2024 after hiring several proven industry leaders to round out the executive team and making key technology investments in 2023. Zilliant also received an additional growth investment from its financial sponsor, Madison Dearborn Partners, to accelerate their vision.

"Pricing is a critical strategic process for every business and its importance has been magnified by shifts in the global economy," said Zilliant CEO Pascal Yammine. "At Zilliant we're honored to be trusted by some of the largest brands in the world as they transform their pricing lifecycle."

Acquisition of In Mind Cloud Draws Additional Funding

In December 2023, Zilliant announced the acquisition of In Mind Cloud. In Mind Cloud's next-generation CPQ complements Zilliant's leading pricing optimization, pricing management and revenue intelligence software to help customers deliver the right price to the right customer at the right time.

Following the acquisition, Madison Dearborn Partners, the Chicago-based private equity investment firm that acquired Zilliant in 2021, increased its investment by $35 million to accelerate product enhancements and other growth initiatives as the company pushes towards its vision of helping customers drive profitable growth by unlocking the power of pricing.

Strengthening the Leadership Team

To help guide Zilliant through this period of exponential growth, the company enhanced its executive team with several proven industry leaders:

Transforming the Pricing Industry

Leaders from across the world will come together at Zilliant's premiere pricing and revenue growth conference, MindShare 2024, taking place on May 21-23 in Austin, Texas. Join other industry leaders for this three-day event featuring best-in-class content, customer success stories and the debut of Zilliant's newest product innovations. Register for MindShare 2024 at Zilliant.com.

About Zilliant

Zilliant helps businesses put pricing at the heart of their business by managing the entire pricing lifecycle. Zilliant's data science, cloud-native software and passion for customer success deliver the highest ROI, fastest time to value and highest customer satisfaction. Learn more about how Zilliant helps businesses unlock the full power of pricing at zilliant.com.


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: